Pig genetics company DanBred has appointed Torben Aarris as the new Chief Executive Officer. He is accompanied by Christen Steffensen, who is appointed the new Chief Financial Officer. Together, the duo will lead the ongoing turnaround process within DanBred.
The 49-year-old Torben Aarris has been appointed CEO of the pig genetics company DanBred. He is currently CEO of the dairy cooperative, Them Andelsmejeri, where he, with his commercial mindset and leadership skills, has directed a turnaround. Previously, Torben Aarris headed the Nordic packaging division of RPC Promens group, for several years. He will enter the new position in DanBred on 1 June 2023.
Additionally, Christen Steffensen has been appointed the new CFO of DanBred and will take over the position on 20 March 2023. Christen has an excellent record across leading companies, amongst others as CFO of Hamlet Protein and Vice President Finance in Chr. Hansen. His passion for understanding complex value chains combined with a deep knowledge of IT makes him an excellent match for Torben Aarris and DanBred.
”I’m happy that we have now finalised the new leadership team for DanBred. Both profiles come with demonstrated leadership competencies as well as a strong commercial background. This will, when combined with the strong technical competencies we already have within the organisation today, give us the upper hand for future positioning of the company and its strengths,” says chairman of the board, Truels Damsgaard, DanBred.
Torben Aarris will replace Claus Fertin, who in January 2023 announced his resignation as CEO of DanBred.
“I am delighted for the opportunity to join DanBred, a professional and knowledge-heavy company, which has the capacity to develop into an even greater player on the global market,” says Torben Aarris.
The appointment of the new management team comes in the wake of a challenging 2022, where a prompt exit from the Russian market, high freight prices, and a generally challenged pig industry in many countries have left their mark. Therefore, a turnaround in the company has now been initiated, and 2023 already seems to have potential to be a significantly better year for DanBred.
“With this addition, we will have skilled management with an international strength, this provides a good starting point for unlocking DanBred’s full potential as a leading genetics supplier in the global market,” says Truels Damsgaard.
For further press information, please visit: DanBred press.
